VEXINE 150 mg


EXTENDED RELEASE TABLETS
scheduling status
S5
registration number
47/1.2/0082
What VEXINE 150 mg contains
VENLAFAXINE.
other ingredients
Ethyl cellulose, hypromellose, methanol, methylene chloride, sugar spheres. Composition of capsule shell: Gelatin, iron oxide black (C.I No. 77499), iron oxide red (C.I. No. 77491), sodium lauryl sulphate, titanium dioxide (C.I. No. 77891). Composition of ink: Black iron oxide (C.I. No. 77499), butyl alcohol, dehydrated alcohol, isopropyl alcohol, potassium hydroxide, propylene glycol, purified water, shellac, strong ammonia solution.
Therapeutic classification
N06AX12.
VEXINE 150 mg
© 2026 SAHPRA. ALL RIGHTS RESERVED